Atossa Genetics, Inc.
Company Information

4105 E Madison St
Seattle, WA, 98112 United States
(206) 325-6086

Top 3 Competitors

Unlock access to over 100 million contacts! Starting at only $50 per user/month*

  • Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and close business.
  • Easy-to-read reports on over 85 million companies and 900 industries build your understanding of the companies you work with.
  • Reports are written by real industry experts. Their summaries save you hours of research.

Unlock a Hoover's Basic Subscription.
To talk to a Business Information Consultant please call (866) 473-3932

*Prices reflect per user/per month cost based on an annual subscription for a minimum of 5 users.


Atossa Genetics, Inc. Company Profile

A development-stage company, Atossa Genetics owns and markets the MASCT (Mammary Aspirate Specimen Cytology Test) System, which was created by Atossa founder Steven Quay and tests for precursors to breast cancer. The MASCT System goes beyond mammograms in that it can detect genetic pre-cancerous conditions in the breast up to eight years before a mammography. Patented and approved by the FDA, the device is a handheld pump used to collect fluid from breast milk ducts in about 10 minutes. Atossa also offers related screening tests. The company filed an initial public offering (IPO) in 2010, but later withdrew the offering; it filed again in 2012.